• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型氮芥类化合物用于骨肉瘤的3D和2D-QSAR模型研究及分子对接

3D- and 2D-QSAR models' study and molecular docking of novel nitrogen-mustard compounds for osteosarcoma.

作者信息

Zhuo Wenkun, Lian Zheng, Bai Wenzhe, Chen Yanrong, Xia Huanling

机构信息

Department of Orthopedics, The 960th Hospital of the Chinese People's Liberation Army, Jinan, China.

Department of Orthopaedics, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.

出版信息

Front Mol Biosci. 2023 Mar 29;10:1164349. doi: 10.3389/fmolb.2023.1164349. eCollection 2023.

DOI:10.3389/fmolb.2023.1164349
PMID:37065446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10090277/
Abstract

The dipeptide-alkylated nitrogen-mustard compound is a new kind of nitrogen-mustard derivative with a strong anti-tumor activity, which can be used as a potential anti-osteosarcoma chemotherapy drug. 2D- and 3D-QSAR (structure-activity relationship quantification) models were established to predict the anti-tumor activity of dipeptide-alkylated nitrogen-mustard compounds. In this study, a linear model was established using a heuristic method (HM) and a non-linear model was established using the gene expression programming (GEP) algorithm, but there were more limitations in the 2D model, so a 3D-QSAR model was introduced and established through the CoMSIA method. Finally, a series of new dipeptide-alkylated nitrogen-mustard compounds were redesigned using the 3D-QSAR model; docking experiments were carried out on several compounds with the highest activity against tumors. The 2D- and 3D-QSAR models obtained in this experiment were satisfactory. A linear model with six descriptors was obtained in this experiment using the HM through CODESSA software, where the descriptor "Min electroph react index for a C atom" has the greatest effect on the compound activity; a reliable non-linear model was obtained using the GEP algorithm model (the best model was generated in the 89th generation cycle, with a correlation coefficient of 0.95 and 0.87 for the training and test set, respectively, and a mean error of 0.02 and 0.06, respectively). Finally, 200 new compounds were designed by combining the contour plots of the CoMSIA model with each other, together with the descriptors in the 2D-QSAR, among which compound I1.10 had a high anti-tumor and docking ability. Through the model established in this study, the factors influencing the anti-tumor activity of dipeptide-alkylated nitrogen-thaliana compounds were revealed, providing direction and guidance for the further design of efficient chemotherapy drugs against osteosarcoma.

摘要

二肽烷基化氮芥化合物是一类新型的具有较强抗肿瘤活性的氮芥衍生物,可作为一种潜在的抗骨肉瘤化疗药物。建立了二维和三维定量构效关系(QSAR)模型来预测二肽烷基化氮芥化合物的抗肿瘤活性。在本研究中,使用启发式方法(HM)建立了线性模型,使用基因表达编程(GEP)算法建立了非线性模型,但二维模型存在较多局限性,因此引入并通过比较分子相似性指数分析(CoMSIA)方法建立了三维QSAR模型。最后,利用三维QSAR模型重新设计了一系列新的二肽烷基化氮芥化合物;对几种抗肿瘤活性最高的化合物进行了对接实验。本实验获得的二维和三维QSAR模型令人满意。本实验通过CODESSA软件使用HM获得了一个具有六个描述符的线性模型,其中描述符“C原子的最小电子反应指数”对化合物活性的影响最大;使用GEP算法模型获得了一个可靠的非线性模型(最佳模型在第89代循环中生成,训练集和测试集的相关系数分别为0.95和0.87,平均误差分别为0.02和0.06)。最后,通过将CoMSIA模型的等高线图相互结合,并结合二维QSAR中的描述符,设计了200种新化合物,其中化合物I1.10具有较高的抗肿瘤和对接能力。通过本研究建立的模型,揭示了影响二肽烷基化氮芥化合物抗肿瘤活性的因素,为进一步设计高效抗骨肉瘤化疗药物提供了方向和指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb9/10090277/18346d3980f3/fmolb-10-1164349-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb9/10090277/0a2a8d83657f/fmolb-10-1164349-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb9/10090277/5ecbd3628f16/fmolb-10-1164349-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb9/10090277/5d5eea5e2bd4/fmolb-10-1164349-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb9/10090277/57aa3a05b4cf/fmolb-10-1164349-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb9/10090277/fc5ff97fe99e/fmolb-10-1164349-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb9/10090277/a3a5583f22fe/fmolb-10-1164349-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb9/10090277/f48b514bb31d/fmolb-10-1164349-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb9/10090277/18346d3980f3/fmolb-10-1164349-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb9/10090277/0a2a8d83657f/fmolb-10-1164349-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb9/10090277/5ecbd3628f16/fmolb-10-1164349-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb9/10090277/5d5eea5e2bd4/fmolb-10-1164349-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb9/10090277/57aa3a05b4cf/fmolb-10-1164349-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb9/10090277/fc5ff97fe99e/fmolb-10-1164349-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb9/10090277/a3a5583f22fe/fmolb-10-1164349-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb9/10090277/f48b514bb31d/fmolb-10-1164349-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb9/10090277/18346d3980f3/fmolb-10-1164349-g008.jpg

相似文献

1
3D- and 2D-QSAR models' study and molecular docking of novel nitrogen-mustard compounds for osteosarcoma.新型氮芥类化合物用于骨肉瘤的3D和2D-QSAR模型研究及分子对接
Front Mol Biosci. 2023 Mar 29;10:1164349. doi: 10.3389/fmolb.2023.1164349. eCollection 2023.
2
3D,2D-QSAR study and docking of novel quinazolines as potential target drugs for osteosarcoma.新型喹唑啉作为骨肉瘤潜在靶向药物的3D、2D-QSAR研究及对接
Front Pharmacol. 2023 Feb 21;14:1124895. doi: 10.3389/fphar.2023.1124895. eCollection 2023.
3
Exploration of 2D and 3D-QSAR analysis and docking studies for novel dihydropteridone derivatives as promising therapeutic agents targeting glioblastoma.探索新型二氢蝶啶酮衍生物作为靶向胶质母细胞瘤的有前景治疗药物的二维和三维定量构效关系分析及对接研究。
Front Pharmacol. 2023 Aug 31;14:1249041. doi: 10.3389/fphar.2023.1249041. eCollection 2023.
4
2D, 3D-QSAR study and docking of vascular endothelial growth factor receptor 3 (VEGFR3) inhibitors for potential treatment of retinoblastoma.用于视网膜母细胞瘤潜在治疗的血管内皮生长因子受体3(VEGFR3)抑制剂的二维、三维定量构效关系研究及对接
Front Pharmacol. 2023 Apr 7;14:1177282. doi: 10.3389/fphar.2023.1177282. eCollection 2023.
5
QSAR Study of Novel 1, 8-Naphthimide Derivatives Targeting Nuclear DNA.靶向核DNA的新型1,8-萘二甲酰亚胺衍生物的定量构效关系研究
Anticancer Agents Med Chem. 2023;23(6):726-733. doi: 10.2174/1871520622666220822010953.
6
QSAR Research of Novel Tetrandrine Derivatives against Human Hepatocellular Carcinoma.新型汉防己甲素衍生物抗人肝癌的定量构效关系研究。
Anticancer Agents Med Chem. 2023;23(19):2146-2153. doi: 10.2174/1871520623666230831103936.
7
Predicting the Efficacy of Novel Synthetic Compounds in the Treatment of Osteosarcoma Anti-Receptor Activator of Nuclear Factor-κB Ligand (RANKL)/Receptor Activator of Nuclear Factor-κB (RANK) Targets.预测新型合成化合物在骨肉瘤治疗中的疗效 抗核因子-κB 配体受体激活剂(RANKL)/核因子-κB 受体激活剂(RANK)靶点。
Med Chem. 2024;20(7):733-740. doi: 10.2174/0115734064287922240222115200.
8
Tit Structure-activity Relationship Study and Design of Novel 1, 8- Naphthimide Derivatives as Potential DNA-targeting Chemotherapeutic Agents for Osteosarcoma.标题:基于结构-活性关系的研究与新型 1,8-萘酰亚胺衍生物的设计,作为潜在的骨肉瘤 DNA 靶向化疗药物。
Med Chem. 2023;19(9):906-914. doi: 10.2174/1573406419666230414144825.
9
Improved 3D-QSAR Prediction by Multiple Conformational Alignments and Molecular Docking Studies to Design and Discover HIV-I Protease Inhibitors.通过多种构象排列和分子对接研究提高 3D-QSAR 预测,以设计和发现 HIV-I 蛋白酶抑制剂。
Curr HIV Res. 2021;19(2):154-171. doi: 10.2174/1570162X18666201119143457.
10
2D and 3D QSAR studies of diarylpyrimidine HIV-1 reverse transcriptase inhibitors.二芳基嘧啶HIV-1逆转录酶抑制剂的二维和三维定量构效关系研究
J Comput Aided Mol Des. 2008 Nov;22(11):831-41. doi: 10.1007/s10822-008-9217-4. Epub 2008 May 28.

引用本文的文献

1
Advances, opportunities, and challenges in methods for interrogating the structure activity relationships of natural products.天然产物结构-活性关系研究方法的进展、机遇与挑战。
Nat Prod Rep. 2024 Oct 17;41(10):1543-1578. doi: 10.1039/d4np00009a.

本文引用的文献

1
Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies.靶向骨肉瘤治疗效果和耐药性的分子机制:当前和未来策略的综述。
Int J Mol Sci. 2020 Sep 19;21(18):6885. doi: 10.3390/ijms21186885.
2
Studies on the bioactivities and molecular mechanism of antioxidant peptides by 3D-QSAR, in vitro evaluation and molecular dynamic simulations.采用 3D-QSAR、体外评价和分子动力学模拟研究抗氧化肽的生物活性和分子机制。
Food Funct. 2020 Apr 30;11(4):3043-3052. doi: 10.1039/c9fo03018b.
3
Therapeutic Potential of Nitrogen Mustard Based Hybrid Molecules.
基于氮芥的杂化分子的治疗潜力
Front Pharmacol. 2018 Dec 17;9:1453. doi: 10.3389/fphar.2018.01453. eCollection 2018.
4
Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives.氮芥作为烷化抗癌药物的治疗历程:从历史到未来展望。
Eur J Med Chem. 2018 May 10;151:401-433. doi: 10.1016/j.ejmech.2018.04.001. Epub 2018 Apr 3.
5
Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss).肢体非转移性骨肉瘤。采用甲氨蝶呤、顺铂、阿霉素和异环磷酰胺进行新辅助化疗。一项意大利肉瘤研究组的研究(ISG/OS-Oss)。
Tumori. 2014 Nov-Dec;100(6):612-9. doi: 10.1700/1778.19262.
6
3D-QSAR modeling and molecular docking study on Mer kinase inhibitors of pyridine-substituted pyrimidines.吡啶取代嘧啶类Mer激酶抑制剂的3D-QSAR建模与分子对接研究
Mol Divers. 2015 Feb;19(1):135-47. doi: 10.1007/s11030-014-9556-0. Epub 2014 Oct 30.
7
Molecular docking, molecular dynamics simulation, and structure-based 3D-QSAR studies on estrogenic activity of hydroxylated polychlorinated biphenyls.对羟基化多氯联苯雌激素活性的分子对接、分子动力学模拟和基于结构的 3D-QSAR 研究。
Sci Total Environ. 2012 Dec 15;441:230-8. doi: 10.1016/j.scitotenv.2012.08.072. Epub 2012 Nov 6.
8
Combined 3D-QSAR, molecular docking and molecular dynamics study on thyroid hormone activity of hydroxylated polybrominated diphenyl ethers to thyroid receptors β.结合 3D-QSAR、分子对接和分子动力学研究羟化多溴联苯醚对甲状腺受体 β 的甲状腺激素活性。
Toxicol Appl Pharmacol. 2012 Dec 15;265(3):300-7. doi: 10.1016/j.taap.2012.08.030. Epub 2012 Sep 6.
9
Molecular modeling on pyrimidine-urea inhibitors of TNF-α production: an integrated approach using a combination of molecular docking, classification techniques, and 3D-QSAR CoMSIA.基于 TNF-α 产生的嘧啶-脲抑制剂的分子建模:使用分子对接、分类技术和 3D-QSAR CoMSIA 相结合的综合方法。
J Chem Inf Model. 2012 Mar 26;52(3):711-23. doi: 10.1021/ci200579f. Epub 2012 Mar 15.
10
Docking, molecular dynamics and quantitative structure-activity relationship studies for HEPTs and DABOs as HIV-1 reverse transcriptase inhibitors.对接、分子动力学和定量构效关系研究作为 HIV-1 逆转录酶抑制剂的 HEPTs 和 DABOs。
J Mol Model. 2012 May;18(5):2185-98. doi: 10.1007/s00894-011-1236-8. Epub 2011 Sep 27.